Substance / Medication

Edrophonium

Overview

Active Ingredient
edrophonium
RxNorm CUI
3752

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
Romano Marta, Martin-Flores Manuel, Sakai Daniel M et al. · Vet Anaesth Analg · 2017
PMID: 29066245RCT
Evaluation of the Edrophonium Challenge Test for Cervical Dystonia.
Matsumoto Shinichi, Murakami Nagahisa, Koizumi Hidetaka et al. · Intern Med · 2017
PMID: 28824069TrialFull text (PMC)
Effects of the anticholinesterase edrophonium on spectral analysis of heart rate and blood pressure variability in humans.
Deschamps Alain, Backman Steven B, Novak Vera et al. · J Pharmacol Exp Ther · 2002
PMID: 11752105Trial
Reversal of mivacurium chloride: edrophonium of spontaneous recovery in microscopic laryngeal surgery.
Ting C K, Lin S M, Yang Y W et al. · Acta Anaesthesiol Sin · 2001
PMID: 11840581Trial
Reversal of rocuronium with edrophonium during propofol versus sevoflurane anesthesia.
Zhou T J, Chiu J W, White P F et al. · Acta Anaesthesiol Scand · 2001
PMID: 11167172Trial
Edrophonium antagonism of cisatracurium-induced neuromuscular block: dose requirements in children and adults.
Abdulatif M, El-Sanabary M · Anaesth Intensive Care · 2001
PMID: 11512646Trial
[Edrophonium chloride (Tensilon) test: a safe method in diagnosing myasthenia gravis].
Domanovits H, Wenger S, Schillinger M et al. · Wien Klin Wochenschr · 2000
PMID: 10944818Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Edrophonium (substance)
SNOMED CT
373342004
UMLS CUI
C0013615
RxNorm CUI
3752

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.